Baron Funds Comments on Foundation Medicine Inc.

Shutterstock photo

Foundation Medicine, Inc. ( FMI ) ("FMI") is a diagnostic lab company that specializes in analyzing the DNA sequence of the most complex cancers. It uses next generation genetic sequencing to find over '…… relevant cancer genes. On top of this, its information technology platform links pharmaceutical companies with oncologists and scientific research. Roche Holdings announced a broad strategic relationship with FMI in January -…-5, buying over 5…% of FMI's shares at $5… per share. Included in the various agreements with Roche are plans to co-market FMI's tests overseas, develop additional high value tests, and use Roche's U.S. sales force to educate medical professionals about the advantages of FMI's technology. We believe FMI is well positioned to take share in the emerging multi-billion dollar complex cancer diagnostics market.

From Baron Opportunity Fund third-quarter -…-6 commentary .
Read More:
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Stocks

More from GuruFocus




Stock Picks, Portfolios

Research Brokers before you trade

Want to trade FX?